Mar 28, 2023 08:00 AM

Shanghai Micurx Pharmaceutical Co.,Ltd. Posted 220.3 Million Yuan Net Loss in 2022

By Caixin Automation

Shanghai Micurx Pharmaceutical Co.,Ltd. (上海盟科药业股份有限公司) (688373.SH) reported a net loss of 220.3 million yuan in 2022, narrowing 2.6% year-on-year.

Meanwhile, the company posted 48.2 million yuan in revenue, up 529.3% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 283.1 million yuan in total liabilities, with a liability-to-asset ratio of 18.9%.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Innovation Takes Off at Flying Vehicle Expo

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: How China’s Crypto Ban Makes Disposing of Seized Assets a Lot Harder

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Factory Exodus Is Turning Vietnam Into the World’s Assembler

2: Meituan Enters Open-Source AI Race With LongCat Model

3: Ex-UBS Banker in Hong Kong Jailed 10 Years for Laundering $17.2 Million

4: Alipay Fined by Luxembourg Regulator for Anti-Money Laundering Breaches

5: End of U.S. Tax Exemption Hits Chinese Air Cargo Carriers Differently

SPONSORED

OR